PetVivo Holdings, Inc. (PETV): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
PetVivo Holdings, Inc. (PETV) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 5151 Edina Industrial Blvd., Suite 575, Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: Michael Handley Joins PetVivo Holdings, Inc. Board of Directors MINNEAPOLIS, MN, US, September 22, 2026 — PetVivo Holdings, Inc. (OTCQX: PETV) (the “Compan
How this was made
The 30-second read
Why it matters
The appointment introduces experienced leadership but does not alter the company's financial outlook immediately.
Market read
A routine governance update with modest relevance for PETV shareholders; unlikely to drive significant price action.
What to watch
Handley's network could unlock future partnerships or financing, which may be undervalued today.
Background
The filing is an SEC Form 8‑K reporting a director resignation and a new board appointment, a standard corporate governance disclosure.
Ticker impact
PetVivo announced the appointment of Michael K. Handley to its Board, filling a vacancy after a director resignation.
Limited short‑term movement; potential modest upside if market views the appointment as value‑adding.
Director appointments are routine corporate actions; the news is new but material impact is uncertain.
Market effects
May signal continued focus on veterinary biotech and device commercialization.
Limited to U.S. OTC market; no broader regional effect.
Low; primarily relevant to investors in PetVivo.
Counterpoint
Board changes rarely move price; investors could ignore and focus on pipeline milestones.
Key entities
- CompanyPetVivo Holdings, Inc.
Emerging biomedical device company focused on veterinary and human health.
- ExecutiveMichael K. Handley
New board member with extensive life‑sciences and capital‑raising experience.
